Celon Pharma S.A.
WSE:CLN.WA
15.96 (PLN) • At close December 14, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) PLN.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 213.921 | 161.915 | 169.559 | 139.27 | 102.247 | 125.245 | 107.12 | 128.778 | 107.54 | 98.099 | 71.64 | 40.109 |
| Kosten van de omzet
| 66.819 | 66.462 | 61.715 | 32.011 | 23.355 | 28.176 | 24.466 | 28.491 | 30.024 | 20.265 | 14.769 | 7.923 |
| Brutowinst
| 147.102 | 95.453 | 107.844 | 107.259 | 78.892 | 97.068 | 82.654 | 100.287 | 77.516 | 77.834 | 56.872 | 32.186 |
| Brutowinstmarge
| 0.688 | 0.59 | 0.636 | 0.77 | 0.772 | 0.775 | 0.772 | 0.779 | 0.721 | 0.793 | 0.794 | 0.802 |
| Onderzoek- en ontwikkelingskosten
| 0.68 | 62.999 | 49.054 | 42.254 | 0 | 0 | 0 | 0 | 0 | 8.856 | 4.409 | 0.97 |
| Algemene en administratieve kosten
| 0 | 0 | 37.384 | 10.948 | 15.878 | 18.336 | 18.685 | 19.175 | 16.445 | 51.431 | 39.066 | 31.601 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 19.533 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 111.12 | 13.103 | 37.384 | 10.948 | 15.878 | 18.336 | 18.685 | 19.175 | 16.445 | 51.431 | 39.066 | 31.601 |
| Overige kosten
| 62.544 | 132.749 | 81.045 | 58.998 | 56.794 | 43.398 | 37.945 | 34.221 | 14.987 | 0 | 0 | 0 |
| Bedrijfskosten
| 174.344 | 132.749 | 118.429 | 69.946 | 72.673 | 61.734 | 56.63 | 53.396 | 31.431 | 19.488 | 34.82 | 29.58 |
| Bedrijfsresultaat
| -27.242 | -34.735 | -13.666 | 36.818 | 6.898 | 35.611 | 25.991 | 47.057 | 47.2 | 29.212 | 21.967 | 2.315 |
| Bedrijfsresultaat ratio
| -0.127 | -0.215 | -0.081 | 0.264 | 0.067 | 0.284 | 0.243 | 0.365 | 0.439 | 0.298 | 0.307 | 0.058 |
| Totaal overige inkomsten en kosten netto
| 7.274 | 0.89 | -4.634 | -1.915 | 0.911 | 1.882 | 4.922 | -0.27 | -0.697 | 28.944 | 0.023 | 0.03 |
| Inkomen voor belasting
| -19.968 | -36.446 | -15.087 | 22.069 | 7.809 | 37.494 | 30.913 | 46.787 | 46.503 | 58.156 | 21.99 | 2.345 |
| Inkomen voor belasting ratio
| -0.093 | -0.225 | -0.089 | 0.158 | 0.076 | 0.299 | 0.289 | 0.363 | 0.432 | 0.593 | 0.307 | 0.058 |
| Belastingkosten
| 8.156 | 2.831 | -3.48 | 0.574 | -4.126 | 7.797 | 5.298 | 8.98 | 9.323 | 5.949 | 4.032 | 1.012 |
| Nettowinst
| -28.124 | -39.277 | -11.607 | 21.495 | 11.935 | 29.697 | 25.615 | 37.807 | 37.18 | 52.207 | 17.958 | 1.334 |
| Nettowinstmarge
| -0.131 | -0.243 | -0.068 | 0.154 | 0.117 | 0.237 | 0.239 | 0.294 | 0.346 | 0.532 | 0.251 | 0.033 |
| WPA (Winst Per Aandeel)
| -0.55 | -0.77 | -0.25 | 0.48 | 0.27 | 0.66 | 0.57 | 0.84 | 0.83 | 1.74 | 0.6 | 0.04 |
| Verwaterde WPA
| -0.55 | -0.77 | -0.25 | 0.48 | 0.27 | 0.66 | 0.57 | 0.84 | 0.83 | 1.74 | 0.6 | 0.045 |
| EBITDA
| 32.714 | 9.32 | 27.808 | 30.37 | 26.839 | 55.853 | 48.538 | 60.824 | 55.055 | 34.362 | 26.286 | 6.654 |
| EBITDA ratio
| 0.153 | 0.058 | 0.164 | 0.218 | 0.262 | 0.446 | 0.453 | 0.472 | 0.512 | 0.35 | 0.367 | 0.166 |